Literature DB >> 29484460

[Human papillomavirus and penile cancer : Thinking about measures for prevention].

P Schneede1, B Schlenker2.   

Abstract

Two major pathways of penile carcinogenesis are known: human papillomavirus (HPV)-induced penile cancer and HPV-negative cancers associated with chronic dermatoses. Therefore, modern measures for prevention of penile cancer may for example include prophylactic HPV vaccination. The resulting B‑cell-mediated immunity to HPV capsid proteins is effective protection against future HPV infections. Contrarily when treating existing HPV infections or HPV-associated cancers an antigen-specific T‑cell immunity is necessary. To date, screening and treatment of precancerous lesions to prevent penile cancer are not established in the German health care program and the highly expected therapeutic HPV vaccines are still on the horizon. In this article, we focus on possible strategies to prevent HPV-related penile cancer on different levels of carcinogenesis.

Entities:  

Keywords:  Cancer screening; Phimosis; Prevention; Squamous cell carcinoma; Vaccination

Mesh:

Substances:

Year:  2018        PMID: 29484460     DOI: 10.1007/s00120-018-0597-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  10 in total

1.  Condylomata acuminata and human genital cancer.

Authors:  H zur Hausen
Journal:  Cancer Res       Date:  1976-02       Impact factor: 12.701

Review 2.  [Buschke-Lowenstein tumors].

Authors:  M Sporkert; A Rübben
Journal:  Hautarzt       Date:  2017-03       Impact factor: 0.751

Review 3.  Current state in the development of candidate therapeutic HPV vaccines.

Authors:  Andrew Yang; Jessica Jeang; Kevin Cheng; Ting Cheng; Benjamin Yang; T-C Wu; Chien-Fu Hung
Journal:  Expert Rev Vaccines       Date:  2016-03-07       Impact factor: 5.217

4.  Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.

Authors:  Ricardo Rosales; Mario López-Contreras; Carlos Rosales; Jose-Roberto Magallanes-Molina; Roberto Gonzalez-Vergara; Jose Martin Arroyo-Cazarez; Antonio Ricardez-Arenas; Armando Del Follo-Valencia; Santiago Padilla-Arriaga; Miriam Veronica Guerrero; Miguel Angel Pirez; Claudia Arellano-Fiore; Freddy Villarreal
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

5.  Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis.

Authors:  M A Rubin; B Kleter; M Zhou; G Ayala; A L Cubilla; W G Quint; E C Pirog
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 6.  [One decade of HPV vaccination in Germany].

Authors:  P Schneede
Journal:  Urologe A       Date:  2017-06       Impact factor: 0.639

7.  [HPV in urology. Basic principles and controversies].

Authors:  P Schneede; R Waidelich
Journal:  Urologe A       Date:  2013-09       Impact factor: 0.639

8.  The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay.

Authors:  Antonio L Cubilla; Belén Lloveras; María Alejo; Omar Clavero; Alcides Chaux; Elena Kasamatsu; Elsa F Velazquez; Cecilia Lezcano; Núria Monfulleda; Sara Tous; Laia Alemany; Joellen Klaustermeier; Nubia Muñoz; Wim Quint; Silvia de Sanjose; Francisco Xavier Bosch
Journal:  Am J Surg Pathol       Date:  2010-01       Impact factor: 6.394

Review 9.  Recent advances in understanding and preventing human papillomavirus-related disease.

Authors:  Karin Hellner; Lucy Dorrell
Journal:  F1000Res       Date:  2017-03-14

Review 10.  Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.

Authors:  P Vici; L Pizzuti; L Mariani; G Zampa; D Santini; L Di Lauro; T Gamucci; C Natoli; P Marchetti; M Barba; M Maugeri-Saccà; D Sergi; F Tomao; E Vizza; S Di Filippo; F Paolini; G Curzio; G Corrado; A Michelotti; G Sanguineti; A Giordano; R De Maria; A Venuti
Journal:  Expert Rev Vaccines       Date:  2016-05-09       Impact factor: 5.217

  10 in total
  5 in total

Review 1.  [Human papillomavirus disease burden in men : HPV prevention is a man's business].

Authors:  P Schneede
Journal:  Urologe A       Date:  2018-12       Impact factor: 0.639

Review 2.  [Penile cancer: diagnosis and staging].

Authors:  K-D Sievert; D-L Dräger; F-M Köhn; S Milerski; C Protzel; O W Hakenberg
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

3.  [Improvement of vaccination activities in urology].

Authors:  Peter Schneede
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

Review 4.  [Molecular characterization of penile cancer : Literature review of new prognostic markers and potential therapeutic targets].

Authors:  M May; S D Brookman-May; T H Ecke; M Burger
Journal:  Urologe A       Date:  2018-04       Impact factor: 0.639

Review 5.  [175 years of anesthesia and narcosis-Towards a "human right to unconsciousness"].

Authors:  K Lewandowski; B Kretschmer; K W Schmidt
Journal:  Anaesthesist       Date:  2021-09-16       Impact factor: 1.041

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.